ARCHIVES

NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract

This article is from The Cancer Letter archive.

Vol. 01 No. 04 | March 1, 1974

Download PDF Visit The Full Archive

Related Articles

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

March 2, 2001

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

November 1, 1985

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

January 27, 2006

ACCC Workshop Set for Sept; Planning Grant Okd

June 6, 1975

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

NEJM Does About-Face, Issues Correction On CT Lung Cancer Screening Study.

April 4, 2008